122 chapter 2 Table 9. Cytological RAS mutation status in histopathologically confirmed malignancies RAS mutation positive malignancies, ni RAS mutation negative malignancies, ni reference PTC FVPTC FTC FTC-OV MTC mPTC other n.s. PTC FVPTC FTC FTC-OV MTC mPTC other n.s. Cantara 2010 2 5 Moses 2010 4 19 4 2 Nikiforov 2011 5 37 3 10 32 6 Mancini 2012 2 2 5 Ohori 2013 1 39 1 1 1 3 5 57 3 1 1 1 Beaudenon 2014 8 3 5 1 Danilovic 2014 13 17 Eszlinger 2014 (1) 2 2 2 16 Eszlinger 2014 (2) 1 3 5 Liu 2014 1 3 2 2 Nikiforov 2014 20 19 Eszlinger 2015 10 1 1 7 11 11 4 Gill 2015 8 15 Giovanella 2015 1 1 1 2 2 4 5 Hwang 2015 26 1 2 5 1 Le Mercier 2015 1 2 1 1 1 1 Nikiforov 2015 11 11 Rossi 2015 1 16 1 Yoon 2015 3 3 1 28 9 1 1 Valderrabano 2016 7 1 1 6 1 1 1 1 TOTAL 21 113 26 2 1 1 6 42 103149 55 16 2 1 3 67 FTC: follicular thyroid carcinoma. FTC-OV: FTC, oncocytic variant (Hürthle cell carcinoma). FVPTC: papillary thyroid carcinoma, follicular variant. mPTC: papillary thyroid microcarcinoma. MTC: medullary thyroid carcinoma. n.s.: not specified. PTC: papillary thyroid carcinoma.
RkJQdWJsaXNoZXIy MTk4NDMw